Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171778 | SCV000050789 | benign | Colorectal cancer | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000123592 | SCV000166931 | benign | not specified | 2011-08-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000123592 | SCV000232692 | benign | not specified | 2015-05-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000123592 | SCV000311253 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000244317 | SCV000317558 | benign | Cardiovascular phenotype | 2015-03-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory for Molecular Medicine, |
RCV000123592 | SCV000538267 | benign | not specified | 2016-04-25 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 5727/13002=44% |
Invitae | RCV000350947 | SCV001000263 | benign | Long QT syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000602690 | SCV001156896 | benign | Long QT syndrome 11 | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000123592 | SCV001361192 | benign | not specified | 2019-08-12 | criteria provided, single submitter | clinical testing | Variant summary: AKAP9 c.1389G>T (p.Met463Ile) results in a conservative amino acid change in the encoded protein sequence. Four of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.38 in 250610 control chromosomes, predominantly at a frequency of 0.51 within the African or African-American subpopulation in the gnomAD database, including 2115 homozygotes. Therefore, suggesting the variant is the major allele found in population(s) of African American origin. Four ClinVar submissions (evaluation after 2014) cite the variant three times as benign and once as likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Genome- |
RCV000602690 | SCV002524818 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000602690 | SCV000734574 | benign | Long QT syndrome 11 | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000123592 | SCV001924686 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000123592 | SCV001958696 | benign | not specified | no assertion criteria provided | clinical testing |